Cite
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies
MLA
Medicina, et al. Intravenous Cyclophosphamide Improves Functional Outcomes in Interstitial Lung Disease Related to Idiopathic Inflammatory Myopathies. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1376895201&authtype=sso&custid=ns315887.
APA
Medicina, Medikuntza, Moreno Torres, V., Martín Iglesias, D., Vivero, F., González Echavarri, C., García Moyano, M., Enghelmayer, J. I., Malfante, P., Gaser, A., Ruiz Irastorza, G., & EPIMAR cohort investigators. (2023). Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Chicago
Medicina, Medikuntza, Víctor Moreno Torres, Daniel Martín Iglesias, Florencia Vivero, Cristina González Echavarri, Marta García Moyano, et al. 2023. “Intravenous Cyclophosphamide Improves Functional Outcomes in Interstitial Lung Disease Related to Idiopathic Inflammatory Myopathies.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1376895201&authtype=sso&custid=ns315887.